ABRAXANE FOR INJECTABLE SUSPENSION
ABRAXANE FOR INJECTABLE SUSPENSION
Approved
DIN Number
02281066
Drug Class
Human
Market Date
Aug 31, 2006
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02281066
AIG Number0124214002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD01 PACLITAXEL
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PACLITAXELActive
Strength: 100 MG / VIAL
Monograph: PACLITAXEL